Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis To File Femara Early Adjuvant NDA In Second Quarter

Jan 20 2005

• By Andrew Kasper

Related Content

Gleevec Could Get Higher Maximum Approved Dose

Jan 20 2004

Novartis Femara Adds Extended Adjuvant Breast Cancer Treatment Indication

Nov 01 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window